Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-32,381
Closed -$1.57M 204
2023
Q4
$1.57M Buy
32,381
+19,062
+143% +$850K 0.24% 110
2023
Q3
$540K Sell
13,319
-10,840
-45% -$429K 0.07% 268
2023
Q2
$953K Sell
24,159
-8,625
-26% -$312K 0.12% 207
2023
Q1
$1.34M Sell
32,784
-577
-2% -$21.2K 0.22% 113
2022
Q4
$1.11M Buy
+33,361
New +$1,000K 0.1% 149
2022
Q2
Sell
-20,564
Closed -$1.07M 391
2022
Q1
$1.07M Sell
20,564
-2,812
-12% -$144K 0.09% 176
2021
Q4
$1.57M Buy
23,376
+3,451
+17% +$248K 0.12% 146
2021
Q3
$1.45M Buy
+19,925
New +$1.46M 0.09% 159

Other funds holding DCBO

Advisory Research's DCBO Position: Q1 2024 in Review

Advisory Research sold out of Docebo (DCBO) in Q1 2024, closing a stake of 32,381 shares — an estimated $1.57M sold.

Advisory Research first reported a position in DCBO in Q3 2021 and held it in 8 quarters. The position peaked at $1.57M in Q4 2021. 106 funds tracked by Wall St. Rank hold DCBO as of Q1 2024.

  • Advisory Research reported no remaining Docebo position as of Q1 2024 after selling out during the quarter.
  • Advisory Research sold 32,381 Docebo shares in Q1 2024, an estimated $1.57M.
  • Advisory Research first reported a position in Docebo in Q3 2021 and held it in 8 quarters.
  • Advisory Research's Docebo position peaked at $1.57M in Q4 2021.
  • 106 funds tracked by Wall St. Rank held Docebo as of Q1 2024.

Based on Advisory Research's 13F filing for Q1 2024, filed 14 May 2024.